nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A phase I study of imatinib mesylate in combination with chlorambucil in previously treated chronic lymphocytic leukemia patients
|
Hebb, Jonathan |
|
2010 |
68 |
3 |
p. 643-651 |
artikel |
2 |
A two-part Phase II study of cediranib in patients with advanced solid tumours: the effect of food on single-dose pharmacokinetics and an evaluation of safety, efficacy and imaging pharmacodynamics
|
Mitchell, Claire L. |
|
2010 |
68 |
3 |
p. 631-641 |
artikel |
3 |
Circulating endothelial cells predict for response to bevacizumab-based chemotherapy in metastatic colorectal cancer
|
Matsusaka, Satoshi |
|
2010 |
68 |
3 |
p. 763-768 |
artikel |
4 |
Cytochrome P450 ω-hydroxylase promotes angiogenesis and metastasis by upregulation of VEGF and MMP-9 in non-small cell lung cancer
|
Yu, Wei |
|
2010 |
68 |
3 |
p. 619-629 |
artikel |
5 |
Effect of ketoconazole-mediated CYP3A4 inhibition on clinical pharmacokinetics of panobinostat (LBH589), an orally active histone deacetylase inhibitor
|
Hamberg, Paul |
|
2011 |
68 |
3 |
p. 805-813 |
artikel |
6 |
Effect of radiation on the penetration of irinotecan in rat cerebrospinal fluid
|
Khatri, Amit |
|
2010 |
68 |
3 |
p. 721-731 |
artikel |
7 |
Effects of endurance training on combined goserelin acetate and doxorubicin treatment–induced cardiac dysfunction
|
Hydock, David S. |
|
2010 |
68 |
3 |
p. 685-692 |
artikel |
8 |
Enhancing cytotoxic agent activity in experimental pancreatic cancer through EMAP II combination therapy
|
Awasthi, Niranjan |
|
2010 |
68 |
3 |
p. 571-582 |
artikel |
9 |
Evaluation of a non cystatin-C-based novel algorithm to calculate individual glomerular filtration rate in cancer patients receiving carboplatin
|
Holweger, Karin |
|
2010 |
68 |
3 |
p. 693-701 |
artikel |
10 |
5-FU-induced neurotoxicity in cancer patients with profound DPD deficiency syndrome: a report of two cases
|
Cordier, Pierre-Yves |
|
2011 |
68 |
3 |
p. 823-826 |
artikel |
11 |
Induction of fetal hemoglobin and ABCB1 gene expression in 9-β-D-arabinofuranosylguanine-resistant MOLT-4 cells
|
Fyrberg, Anna |
|
2010 |
68 |
3 |
p. 583-591 |
artikel |
12 |
Involvement of RhoA and RalB in geranylgeranyltransferase I inhibitor-mediated inhibition of proliferation and migration of human oral squamous cell carcinoma cells
|
Hamada, Masakazu |
|
2010 |
68 |
3 |
p. 559-569 |
artikel |
13 |
Methylseleninic acid inhibits HDAC activity in diffuse large B-cell lymphoma cell lines
|
Kassam, Shireen |
|
2011 |
68 |
3 |
p. 815-821 |
artikel |
14 |
Modulatory effects of curcumin on multi-drug resistance-associated protein 5 in pancreatic cancer cells
|
Li, Yan |
|
2010 |
68 |
3 |
p. 603-610 |
artikel |
15 |
Over-expression of MDR1 in amrubicinol-resistant lung cancer cells
|
Takakuwa, Osamu |
|
2010 |
68 |
3 |
p. 669-676 |
artikel |
16 |
Pharmacokinetics of aprepitant and dexamethasone after administration of chemotherapeutic agents and effects of plasma substance P concentration on chemotherapy-induced nausea and vomiting in Japanese cancer patients
|
Takahashi, Toshiaki |
|
2010 |
68 |
3 |
p. 653-659 |
artikel |
17 |
Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats
|
Kapetanovic, Izet M. |
|
2010 |
68 |
3 |
p. 593-601 |
artikel |
18 |
Pharmacokinetics, pharmacodynamics and metabolism of the dimeric pyrrolobenzodiazepine SJG-136 in rats
|
Reid, Joel M. |
|
2010 |
68 |
3 |
p. 777-786 |
artikel |
19 |
Phase II study of sequential treatment with S-1 and cisplatin for metastatic gastric cancer
|
Baba, Eishi |
|
2010 |
68 |
3 |
p. 611-617 |
artikel |
20 |
Phase 1 study of conatumumab, a pro-apoptotic death receptor 5 agonist antibody, in Japanese patients with advanced solid tumors
|
Doi, T. |
|
2010 |
68 |
3 |
p. 733-741 |
artikel |
21 |
Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC)
|
Cho, Eun Yoon |
|
2010 |
68 |
3 |
p. 753-761 |
artikel |
22 |
Preoperative radiotherapy with capecitabine and mitomycin C in locally advanced rectal carcinoma
|
Stojanovic, Suzana |
|
2010 |
68 |
3 |
p. 787-793 |
artikel |
23 |
Primary tumor and patient characteristics in breast cancer as predictors of adjuvant therapy regimen: a regression model
|
Francescutti, Valerie |
|
2010 |
68 |
3 |
p. 661-668 |
artikel |
24 |
Prospective multicenter study to investigate the introduction rate of second-line S-1 in gemcitabine-refractory unresectable pancreatic cancer
|
Kawashima, Hiroki |
|
2010 |
68 |
3 |
p. 677-683 |
artikel |
25 |
Role of platelet-activating factor in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice
|
Soares, Pedro M. G. |
|
2010 |
68 |
3 |
p. 713-720 |
artikel |
26 |
Sunitinib in combination with paclitaxel plus carboplatin in patients with advanced solid tumors: phase I study results
|
Heath, Elisabeth I. |
|
2010 |
68 |
3 |
p. 703-712 |
artikel |
27 |
The role of Tau protein in resistance to paclitaxel
|
Smoter, Marta |
|
2011 |
68 |
3 |
p. 553-557 |
artikel |
28 |
The slow cell death response when screening chemotherapeutic agents
|
Blois, Joseph |
|
2010 |
68 |
3 |
p. 795-803 |
artikel |
29 |
Thymidylate synthase and thymidine phosphorylase as predictive markers of capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer
|
Lee, Su Jin |
|
2010 |
68 |
3 |
p. 743-751 |
artikel |
30 |
Weekly paclitaxel in patients with recurrent or metastatic head and neck cancer
|
Tahara, M. |
|
2010 |
68 |
3 |
p. 769-776 |
artikel |